Glipizide NDC 72888-115

Product information

Brand name (proprietary)

Glipizide

Generic name (nonproprietary)

glipizide

Active ingredients

Glipizide — 2.5 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Advagen Pharma Limited

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 214874

Marketing start

Oct 3, 2023

Listing expires

Dec 31, 2027

Other FDA classes

Sulfonylurea Compounds (Chemical structure)

Identifiers

Product ID 72888-115_4c5799dd-65b6-d94e-e063-6294a90a066bSPL ID 4c5799dd-65b6-d94e-e063-6294a90a066bSPL set ID e954afb8-52eb-416a-8f1b-14b0fcb3bac2RxCUI 310488, 310490, 379804, 2737151UNII X7WDT95N5CUPC 0372888117003, 0372888116303, 0372888231051, 0372888231013, 0372888117010, 0372888117300, 0372888115306, 0372888116051, 0372888116013, 0372888115009, 0372888115016, 0372888116006, 0372888117058, 0372888115054, 0372888231006

Pharmacologic class

Sulfonylurea

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472888011500 followed by a unit qualifier and the quantity Copy

Package 72888-0115-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 214874

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.